Porencephaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2940OMIM:175780Q04.6
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Porencephaly (also known as porencephalic cyst or familial porencephaly) is a rare neurological condition characterized by the presence of fluid-filled cysts or cavities within the brain parenchyma, typically communicating with the lateral ventricles and/or the subarachnoid space. These cavities most commonly result from destruction of brain tissue and can occur due to vascular events (such as prenatal stroke), infections, trauma, or genetic causes. Familial porencephaly (type 1, OMIM 175780) is caused by heterozygous mutations in the COL4A1 gene on chromosome 13q34, while porencephaly type 2 (OMIM 614483) is associated with mutations in the COL4A2 gene. These genes encode components of type IV collagen, which is critical for the structural integrity of blood vessel basement membranes, making affected individuals susceptible to hemorrhagic events in the developing brain. The clinical presentation of porencephaly is highly variable, depending on the size, location, and number of cysts. Common manifestations include hemiplegia or hemiparesis (weakness on one side of the body), seizures (including infantile spasms), intellectual disability, developmental delay, speech and language difficulties, and hydrocephalus. Some individuals may have relatively mild symptoms, while others experience severe neurological impairment. Additional features in familial forms related to COL4A1/COL4A2 mutations may include small vessel disease, migraine with aura, Raynaud phenomenon, and eye abnormalities such as retinal arteriolar tortuosity. There is no cure for porencephaly, and treatment is primarily supportive and symptomatic. Management may include anticonvulsant medications for seizure control, physical and occupational therapy for motor deficits, speech therapy, and special education services. In cases complicated by progressive hydrocephalus, neurosurgical intervention such as ventriculoperitoneal shunt placement or cyst fenestration may be necessary. Genetic counseling is recommended for families with the hereditary form. Prognosis varies widely based on the extent of brain involvement and the underlying etiology.

Clinical phenotype terms— hover any for plain English:

Porencephalic cystHP:0002132
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Porencephaly.

View clinical trials →

No actively recruiting trials found for Porencephaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Porencephaly community →

Specialists

1 foundView all specialists →
HM
Hugues CHABRIAT, MD,PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Porencephaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open PorencephalyForum →

No community posts yet. Be the first to share your experience with Porencephaly.

Start the conversation →

Latest news about Porencephaly

No recent news articles for Porencephaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Porencephaly

What is Porencephaly?

Porencephaly (also known as porencephalic cyst or familial porencephaly) is a rare neurological condition characterized by the presence of fluid-filled cysts or cavities within the brain parenchyma, typically communicating with the lateral ventricles and/or the subarachnoid space. These cavities most commonly result from destruction of brain tissue and can occur due to vascular events (such as prenatal stroke), infections, trauma, or genetic causes. Familial porencephaly (type 1, OMIM 175780) is caused by heterozygous mutations in the COL4A1 gene on chromosome 13q34, while porencephaly type 2

At what age does Porencephaly typically begin?

Typical onset of Porencephaly is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Porencephaly?

1 specialists and care centers treating Porencephaly are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.